In a nut shell, I saw Butterfly Network as a medical break through and bought a few hundred shares at a $1.55/shr. and the following news confirmed my reasoning of buying; On November 17, 2025, Butterfly Network’s subsidiary signed a five-year co-development and licensing agreement with Midjourney for exclusive access to its semiconductor-based ultrasound technology, securing a US$15 million upfront payment, US$10 million annual license fees, and further milestone and revenue-sharing potential.Read more
Butterfly Network is betting that smarter software and easier-to-use portable ultrasound can move from niche tool to standard equipment across hospitals, home care, and fast-growing health systems around the world. The big question is whether it can turn early momentum into steady subscription-like income before cash burn, budget-tight hospitals, and stronger rivals force it to lean on lower-profit device sales.Read more
Butterfly Network is trying to make ultrasound easier to use anywhere, pairing handheld scanners with software that helps clinicians capture images and document visits with less friction. New AI features, bigger hospital rollouts, and home‑care pilots could lift adoption, but slow deal timelines, uneven demand, and leadership turnover could hold back progress.Read more
Butterfly Network looks like it could ride the shift toward remote care, but slow-moving hospital purchasing, cautious clinicians, and shaky global health budgets may keep growth from taking off. With heavy spending and customers cancelling software subscriptions, the big question is whether the platform can scale before cash burn forces more fundraising.Read more
Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user’s smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market. It also provides Compass AI which offers one system to connect every device, workflow, and department; ScanLab, an AI-powered educational platform that provides written walkthroughs and reference imagery to guide real-time educational scanning; and Butterfly iQ+/iQ3 Vet, a third generation handheld ultrasound system. It sells and markets its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.
